Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.1
-268.22%
20%
—
8x
60%
—
5 Years
Score3.1
Net Growth-268.22%
Net Trend20%
Net Income Consistency—
Rev Growth8x
Rev Trend60%
Revenue Consistency—
Ideaya Biosciences Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 19M to $ 218M and net income went from -$ 32M to -$ 113M. Revenue increased in 3 of those 5 years; net income in 1.
Ideaya Biosciences Inc currently holds a 5-year HDB Score of 3.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 36.96 | — |
1 Year2025-08-12 | $ 23.59 | 56.68% |
5 Years2021-08-12 | $ 22.76 | 62.39% |
All Time2019-05-23 | $ 11.19 | 230.29% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-05-23 |
|---|---|---|---|---|
| Price | $ 36.96 | $ 23.59 | $ 22.76 | $ 11.19 |
| Return | — | 56.68% | 62.39% | 230.29% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 234M | -$ 175M | $ 828M |
| 2025 | $ 218M | -$ 113M | $ 639M |
| 2024 | $ 7M | -$ 274M | $ 676M |
| 2023 | $ 23M | -$ 112M | $ 525M |
| 2022 | $ 50M | -$ 54M | $ 364M |
| 2021 | $ 27M | -$ 47M | $ 246M |
| 2020 | $ 19M | -$ 32M | $ 283M |
| IPO2019 | $ 0.00 | -$ 38M | $ 98M |
Explore beyond IDYA
You're looking at Ideaya Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
